|
COMMERCE BUSINESS DAILY ISSUE OF JANUARY 17,1997 PSA#1764National Institute of Allergy and Infectious Diseases, Contract
Management Branch, Solar Building, Room 3C07, 6003 Executive Blvd. MSC
7610, Rockville, MD 20892-7610 A -- HOUSING, CARE, AND IMPLEMENTATION OF AIDS RESEARCH PROTOCOLS S
WITH EXPERIMENTALLY-INFECTED CHIMPANZEES SOL RFP-NIH-NIAID-DAIDS-97-10
POC Kristiane Cooper, Contract Specialist, (301) 496-7288. Lawrence M.
Butler, Contracting Officer, (301) 496-0192 The Vaccine and Prevention
Research Program, Division of AIDS, NIAID, NIH, intends to negotiate
a 2 year contract with The Coulston Foundation for housing,
maintaining, and observing 12 particular experimental chimpanzees
through studies which are currently underway through a NCI contract.
Studies performed by Coulston on these chimps are in support of NIAID's
efforts toward finding a safe and efficacious vaccine against the human
immunodeficiency virus type 1 (HIV-1) or AIDS. These particular animals
are infected with HIV-1 and must be utilized because they are the
subject of unfinished ongoing work which must be continued and seen to
ultimate completion. The contractor's responsibilities include: i)
housing, maintaining, and observing the chimpanzees in appropriate and
secure biohazard containment facilities in compliance with USDA
regulations pertaining to primate care; ii) developing study protocols
for scheduling immunizations, specimen collection, etc.; iii)
executing approved protocols (e.g., immunizations, virus challenges)
collecting specimens, recording observations, and reporting them
periodically to the project officer; iv) performing in vitro laboratory
assays to assess immune responses and viral parameters in the chimps;
and v) storing and maintaining inventory of titered virus stocks,
candidate vaccines, and collected specimens. Because the animals are
indeed unique, reproduction of the experimental system in other chimps
by another contractor is unfeasible, if not impossible, and any
attempts would result in unacceptable delays to the vaccine research
effort. In addition, loss of these chimps would be unacceptable because
of the scarcity of chimpanzees, their cost, and the concomitant loss of
knowledge that would come from not observing these particular animals
further. Since Coulston is in possession of these chimps, it is by
necessity the only source capable of continuing these studies. See Note
22. (0015) Loren Data Corp. http://www.ld.com (SYN# 0008 19970117\A-0008.SOL)
A - Research and Development Index Page
|
|